Miri Wernli
President chez MIND MEDICINE (MINDMED) INC.
Fortune : 775 847 $ au 30/04/2024
Postes actifs de Miri Wernli
Sociétés | Poste | Début | Fin |
---|---|---|---|
MIND MEDICINE (MINDMED) INC. | President | 01/02/2021 | - |
Directeur/Membre du Conseil | 28/02/2020 | 11/08/2022 | |
Corporate Officer/Principal | 13/08/2020 | 01/02/2021 |
Historique de carrière de Miri Wernli
Anciens postes connus de Miri Wernli
Sociétés | Poste | Début | Fin |
---|---|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01/01/2007 | 01/01/2016 |
MELODIOL GLOBAL HEALTH LIMITED | Directeur/Membre du Conseil | - | - |
Directeur Général | - | 15/08/2020 | |
Directeur Technique/Scientifique/R&D | 15/08/2020 | - | |
Fondateur | 20/11/2015 | - |
Formation de Miri Wernli
University of Geneva | Doctorate Degree |
Stanford University | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 4 |
Australie | 2 |
Suisse | 2 |
Opérationnelle
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
MELODIOL GLOBAL HEALTH LIMITED | Health Technology |
MIND MEDICINE (MINDMED) INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
- Bourse
- Insiders
- Miri Wernli
- Expérience